Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed

Xin Shelley Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2348-8005; OpenAlex author ID A5032101004; NIH RePORTER profile ID 7366601. Sources: ClinicalTrials.gov.

Their work

Papers
1 (first author 1, last author 0)
Trials
2 (principal investigator on 2)
Grants
1
Labs led
1
Collaborators
3
Papers, trials and grants by year

2008: 2 trials · 2009: none · 2010: none · 2011: none · 2012: none · 2013: 1 grant · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 1

  1. A Randomized, Placebo-Controlled, Double-Blind Study of Minocycline for Reducing the Symptom Burden Experienced by Patients With Advanced Pancreatic Cancer. First author DOI 10.1016/j.jpainsymman.2020.01.007↗

Trials 2

  1. Identifying the Role of Symptom Outcomes and Biomarkers in Survival in Patients With Metastatic Pancreatic Cancer Principal investigator NCT00805688↗
  2. Validating M.D. Anderson Symptom Inventory (MDASI-GI) in GI Cancer Patients Under Chemotherapy Principal investigator NCT00849979↗

Grants 1

  1. Effectiveness of minocycline for reducing symptoms in pancreatic cancer patients R21CA158902↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Qiuling Shi · 1 shared paper, 2020 · strength 0.12
  2. Mona J. Kamal · 1 shared paper, 2020 · strength 0.12
  3. David R. Fogelman · 1 shared paper, 2020 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.